Past Forum: 2023
Boston
Summary
The ninth annual World Medical Innovation Forum was at a new venue, Westin Seaport Boston.
This year, we gathered to discuss the extraordinary opportunities in CNS/Brain Health, Oncology, Inflammation & Immunology and the profound impact they will have on medicine. In more than thirty sessions over the course of three days, Mass General Brigham’s Harvard faculty, industry experts and leading investors and entrepreneurs explored the technologies and challenges as we continue to bring life-changing breakthroughs to our patients and millions around the world.
The World Medical Innovation Forum was established to reaffirm the importance of collaborative innovation—academia, industry and government working together to create solutions for medicine’s great challenges. Our goal is to provide actionable insights for Forum participants. We are grateful to the nearly 200 senior executives, investors, Harvard clinicians and investigators who shared their perspectives as speakers.
Speakers
Tazeen Ahmad
Managing Director, Global Research, BofA Securities
Mark Albers, MD, PhD
Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; Assistant Professor of Neurology, HMS
Fabrisia Ambrosio, PhD
Atlantic Charter Director of the Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute, Spaulding Rehabilitation Hospital; Faculty, HMS
Paul Anderson, MD, PhD
Acting Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
Rox Anderson, MD
Lancer Endowed Chair of Dermatology; Director, Wellman Center for Photomedicine, MGH; Professor of Dermatology, HMS
Brian Anderson, MD
Chief Digital Health Physician, MITRE
Steven Arnold, MD
Director, Alzheimer’s Clinical & Translational Research Unit, Translational Neurology Head & Managing Director, Interdisciplinary Brain Center, MGH; Professor of Neurology, HMS
Natalie Artzi, PhD
Associate Bioengineer, BWH; Associate Professor of Medicine, HMS
Lindsey Baden, MD
Vice President Clinical Research, BWH; Professor, HMS
Chip Baird
CFO, 2seventy bio
Tom Barnes, PhD
CEO, Orna Therapeutics
Elisabeth Battinelli, MD, PhD
Physician, BWH; Associate Professor, HMS
James Berry, MD
Neurologist/ALS Clinical Researcher, MGH; Associate Professor, HMS
John Bishai, PhD
Managing Director, Healthcare Investment Banking, BofA Securities
Stephen Brady
CEO, Tempest Therapeutics
Diana Brainard, MD
CEO, AlloVir
Andy Bressler
Managing Director, Global Research, BofA Securities
Remy Brim, PhD
Principal, BGR Group
David Brown, MD
President, Mass General Hospital; MGH Trustees Professor of Emergency Medicine, HMS
Cait Brumme
CEO, MassChallenge
Greg Butz
Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities
Robert Califf, MD
Commissioner, US Food and Drug Administration
Ruth Carlos, MD
Professor of Radiology, University of Michigan
Sree Chaguturu, MD
Senior Vice President and Chief Medical Officer CVS Health
Li Chai, MD
Pathologist and Principal Investigator, BWH; Associate Professor of Pathology, HMS
Miceal Chamberlain
President, Massachusetts, Bank of America
Janice Chen, PhD
Co-Founder & CTO, Mammoth Biosciences
Michael Cherny
Managing Director, Senior Equity Research Analyst, BofA Securities
Susan Chor
Equity Research Associate, BofA Securities
Chris Coburn
Chief Innovation Officer, Mass General Brigham
Joshua Cohen
Co-CEO, Amylyx Pharmaceuticals
Karen Costenbader, MD
Director, Lupus Program, BWH; Professor of Medicine, HMS
Merit Cudkowicz, MD
Chair, Department of Neurology, MGH; Julieanne Dorn Professor of Neurology, HMS
Olivier Danos, PhD
EVP and Chief Scientific Officer, REGENXBIO
Steve Davis
CEO, Acadia Pharmaceuticals
Shawn Demehri, MD, PhD
Director, High Risk Skin Cancer Clinic, MGH; MGH Research Scholar; Associate Professor, HMS
Ann DeWitt, PhD
General Partner, The Engine
Synho Do, PhD
Director, Lab of Medical Imaging and Computation, Mass General Brigham; Assistant Professor, HMS
Gerard Doherty, MD
Surgeon-in-Chief, BWH; Moseley Professor of Surgery, HMS
Mikael Dolsten, MD, PhD
Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer
Chadi El Saleeby, MD
Associate Pediatrician, Mass General for Children; Assistant Professor of Pediatrics, HMS
Conor Evans, PhD
Principal Investigator, Wellman Center for Photomedicine, MGH; Associate Professor, HMS
Maurizio Fava, MD
Chair of Psychiatry, MGH; Slater Family Professor of Psychiatry, HMS
Florian Fintelmann, MD
Radiologist, Physician-Scientist, MGH; Associate Professor of Radiology, HMS
Keith Flaherty, MD
Director of Clinical Research, Mass General Cancer Center; Professor of Medicine, HMS
Jean-François Formela, MD
Partner, Atlas Venture
Pat Fortune, PhD Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
Said Francis
SVP, Business Development and Corporate Strategy, Moderna
Johannes Fruehauf, MD, PhD
Founder & General Partner, Mission BioCapital; Co-Founder & President, LabCentral; CEO, BioLabs
Niyum Gandhi
Chief Financial Officer, Mass General Brigham
Michael Gapen, PhD
Head of US Economics Research, Bank of America
Arpa Garay
Chief Commercial Officer, Moderna
Lilit Garibyan, MD, PhD
Physician-Scientist, Wellman Center for Photomedicine, MGH; Associate Professor of Dermatology, HMS
Deborah Geraghty, PhD
President & CEO, Anokion
Jason Gerberry
Biopharma Equity Research Analyst, Bank of America
Laura Germine, PhD
Co-Director of the Institute for Technology in Psychiatry, President of the Many Brains Project, McLean Hospital; Associate Professor of Psychiatry, HMS
Craig Gordon, MD
Founder, CEO & CIO, GordonMD Global Investments
Scott Gottlieb, MD
Former Commissioner, Food and Drug Administration (2017-2019)
Ellen Gravallese, MD
Chief of Rheumatology, Inflammation, and Immunity, BWH; Theodore Bevier Bayles Professor of Medicine, HMS
Steven Greenberg, MD
Neurologist, BWH; Professor of Neurology, HMS
Daniel Haber, MD, PhD
Director, Mass General Cancer Center; Kurt J. Isselbacher Professor of Oncology, HMS
Roger Hajjar, MD
Director, Gene & Cell Therapy Institute Mass General Brigham
Alexandria Hammond, PhD
Vice President, Global Research, BofA Securities
Yvonne Hao
Secretary of Economic Development, Commonwealth of Massachusetts
Adam Harpool
Principal, Health & Digital, Oliver Wyman
Steve Harr, MD
President & CEO, Sana Biotechnology
Greg Harrison
Vice President, Global Research, BofA Securities
Maura Healey
Governor of the Commonwealth of Massachusetts
Adi Hoess, MD, PhD
CEO, Affimed
Natalie Holles
CEO, Third Harmonic Bio
Zachary Hornby
CEO, Boundless Bio
Tom Hubbard
Senior Vice President, Network for Excellence in Health Innovation (NEHI)
Ole Isacson, MD, PhD
Director, Neuroregeneration Research Institute, McLean Hospital; Professor of Neurology and Neuroscience, HMS
Tatjana Jakobs, MD
Associate Scientist, Schepens Eye Research Institute of Mass Eye and Ear; Associate Professor of Ophthalmology, HMS
Russell Jenkins, MD, PhD
Investigator, Center for Cancer Research, MGH; Assistant Professor of Medicine, HMS
Kevin Judice, PhD
CEO & Founder, DICE Therapeutics
Rosana Kapeller, MD, PhD
CEO, ROME Therapeutics
Barry Kappel, PhD
Founder, President & CEO, Sapience Therapeutics
Tariq Kassum, MD
CEO, Celsius Therapeutics
Keith Kerman, MD
Operating Partner & Senior Advisor, The Riverside Company
Rachna Khosla
Senior Vice President, Business Development, Amgen
Roger Kitterman
Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
Justin Klee
Co-CEO, Amylyx Pharmaceuticals
Anne Klibanski, MD
President & CEO, Mass General Brigham
Adam Koppel, MD, PhD
Partner, Bain Capital Life Sciences
Vesela Kovacheva, MD, PhD
Director of Translational and Clinical Research, BWH; Assistant Professor of Anesthesia, HMS
Jonathan Kraft
President, The Kraft Group; Chairman, Board of Trustees, MGH
Vijay Kuchroo, DMV, PhD
Director, Evergrande Center for Immunologic Diseases, BWH; Samuel L. Wasserstrom Professor of Neurology, HMS
Clotilde Lagier-Tourenne, MD, PhD
Araminta Broch-Healey Endowed Chair in ALS, MGH; Associate Professor of Neurology, HMS
Adam Landman, MD
Chief Information Officer and Senior Vice President, Digital, Mass General Brigham Associate Professor of Emergency Medicine, HMS
Corinne Le Goff, PharmD
President & CEO, Imunon
Nicole LeBoeuf, MD
Chief of Oncodermatology, BHW; Vice Chair of Dermatology, Dana-Farber Brigham Cancer Center; Associate Professor of Dermatology, HMS
John Lepore, MD
SVP, Head of Research, GSK
Zhen Li, PhD
President & CEO, ADARx Pharmaceuticals
Katherine Liao, MD
Associate Physician, Department of Rheumatology, Inflammation, and Immunity, BWH; Associate Professor of Medicine and Biomedical Informatics, HMS
Evan Lippman
Chief Corporate Development & Strategy Officer, Alnylam
Bill Lundberg, MD
CEO, Merus
Ivana Magovcevic-Liebisch, PhD
President & CEO, Vigil Neuroscience
David Main
CEO, Notch Therapeutics
Tanya Mayadas, PhD
Senior Staff Scientist, BWH; Professor of Pathology, HMS
Ralph Mazitschek, PhD
Principal Investigator, MGH Assistant Professor, HMS
Geoff Meacham, PhD
Managing Director, Global Research, BofA Securities
Aamir Mecklai
Managing Director, Healthcare Investment Banking, BofA Securities
Adrian Mee
Managing Director, Head of Global Healthcare Investment Banking, BofA Securities
Vimal Mehta, MD
CEO, BioXcel Therapeutics
Joan Miller, MD
Chief of Ophthalmology, Mass Eye and Ear and MGH; Ophthalmologist-in-Chief, BWH; David Glendenning Cogan Professor of Ophthalmology, HMS
Jodie Morrison
CEO, Q32 Bio
Brian Moynihan
Chair & CEO, Bank of America
Sumit Mukherjee
Managing Director, Co-Head of Origination, Americas Equity Capital Markets, BofA Securities
Peter Neumann, ScD
Director-CEVR, Tufts Medical Center
Steven Pearson, MD
President, Institute for Clinical and Economic Review; Lecturer, Department of Population Medicine, HMS
James Porter, PhD
CEO, Nuvalent
Yakeel Quiroz, PhD
Director, Familial Dementia Neuroimaging Lab and Director, Multicultural Alzheimer’s Prevention Program, MGH; Paul B. and Sandra M. Edgerley MGH Research Scholar; Associate Professor, HMS
Noopur Raje, MD
Director, Center for Multiple Myeloma, Mass General Cancer Center; Professor of Medicine, HMS
Kerry Ressler, MD, PhD
Chief Scientific Officer, McLean Hospital; Professor of Psychiatry, HMS
Lisa Ricciardi
President & CEO, Cognition Therapeutics
Ryan Richardson
Chief Strategy Officer, BioNTech
David Ricks
Chair & CEO, Eli Lilly and Company
Kasper Roet, PhD
CEO & Co-Founder, QurAlis
Cheryl Sadro
Chief Financial Officer, UC Davis Health
Robert Scannevin, PhD
Chief Scientific Officer, Verge Genomics
Andrew Schiermeier, PhD
President & CEO, AvenCell Therapeutics
Thomas Schuetz, MD, PhD
CEO & Co-Founder, Compass Therapeutics
Fred Schwarzer
CEO, IGM Biosciences
Lynn Seely, MD
President & CEO, Lyell
Stephanie Seminara, MD
Chief, Reproductive Endocrine Unit, MGH; Professor of Medicine, HMS
Laura Sepp-Lorenzino, PhD
Executive Vice President, Chief Scientific Officer, Intellia Therapeutics
Nimish Shah
Partner, Venrock
Munjal Shah
Co-Founder & CEO, Hippocratic AI
Angela Shen, MD
Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
Samantha Singer
President & CEO, Abata Therapeutics
Varun Singh, PhD
President & Co-Founder, Moveworks
Jordan Smoller, MD, ScD
Associate Chief for Research and Director, Center for Precision Psychiatry, Department of Psychiatry, MGH; Tepper Family MGH Research Scholar; Professor of Psychiatry, HMS
Jeffrey Sparks, MD
Associate Physician, BWH; Associate Professor of Medicine, HMS
Paula Ness Speers
Co-Founder & Senior Advisor, Health Advances
Scott Sperling
Co-CEO, Thomas H. Lee Partners; Chairman of the Board, Mass General Brigham
Jason Springs
Co-Founder & CEO, Endpoint Health
Catherine Stehman-Breen, MD
CEO, Chroma Medicine
Alec Stranahan, PhD
Vice President, Global Research, BofA Securities
Marc Succi, MD
Executive Director, Mass General Brigham MESH Incubator; Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; Strategic Innovation Leader, Mass General Brigham Innovation
Rudolph Tanzi, PhD
Director, Genetics and Aging Research Unit, Co-Director, McCance Center for Brain Health, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
David Ting, MD
Associate Clinical Director for Innovation, Mass General Cancer Center; Associate Professor of Medicine, HMS
Meg Tirrell
Medical Correspondent, CNN
R. Nolan Townsend
CEO, LEXEO Therapeutics
Andre Turenne
CEO, Matchpoint Therapeutics
Chris Viehbacher
President & CEO, Biogen
Brian Wainger, MD, PhD
Trustees Endowed Scholar in Anesthesia and Alexander Healey Endowed Chair in ALS, Neurology & Anesthesia, Critical Care and Pain Medicine, MGH; Associate Professor, HMS
Robert Waldinger, MD
Director, Harvard Study of Adult Development, MGH; Professor of Psychiatry, HMS
Kate Walsh
Secretary of Health and Human Services, State of Massachusetts
Philip Wang, MD, DrPH
Director of the Center for Learning Health Systems, BWH; Professor of the Practice of Psychiatry, HMS
Brittany Weber, MD, PhD
Director, Cardio-Rheumatology Clinic, Associate Physician, Prevention Cardiology and Cardiovascular Imaging, BWH; Instructor of Medicine, HMS
Renee Wegrzyn, PhD
Director, Advanced Research Projects Agency for Health
Rachel Whooten, MD
Pediatric Endocrinologist, MGH; Assistant Professor, HMS
Troy Wilson, PhD
President & CEO, Kura Oncology
Charlie Yang, PhD
Vice President, US Biopharmaceutical Equity Research Analyst, BofA Securities
Jason Zemansky, PhD
Vice President, Global Research, BofA Securities
Panels
Monday, June 12, 2023
First Look: 8 rapid fire presentations
- Moderator: Paul Anderson, MD, PhD, Acting Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
- Moderator: Roger Kitterman, Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
Presenters:
- Mark Albers, MD, PhD, Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; Assistant Professor of Neurology, HMS
- Yakeel Quiroz, PhD, Director, Familial Dementia Neuroimaging Lab and Director, Multicultural Alzheimer’s Prevention Program, MGH; Paul B. and Sandra M. Edgerley MGH Research Scholar; Associate Professor, HMS
- Tanya Mayadas, PhD, Senior Staff Scientist, BWH; Professor of Pathology, HMS
- Synho Do, PhD, Director, Lab of Medical Imaging and Computation, Mass General Brigham; Assistant Professor, HMS
- Tatjana Jakobs, MD, Associate Scientist, Schepens Eye Research Institute of Mass Eye and Ear; Associate Professor of Ophthalmology, HMS
- Russell Jenkins, MD, PhD, Investigator, Center for Cancer Research, MGH; Assistant Professor of Medicine, HMS
- Clotilde Lagier-Tourenne, MD, PhD, Araminta Broch-Healey Endowed Chair in ALS, MGH; Associate Professor of Neurology, HMS
- Kerry Ressler, MD, PhD, Chief Scientific Officer, McLean Hospital; Professor of Psychiatry, HMS
First Look: 8 rapid fire presentations
- Moderator: Paul Anderson, MD, PhD, Acting Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
- Moderator: Roger Kitterman, Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
Presenters:
- Fabrisia Ambrosio, PhD, Atlantic Charter Director of the Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute, Spaulding Rehabilitation Hospital; Faculty, HMS
- Li Chai, MD, Pathologist and Principal Investigator, BWH; Associate Professor of Pathology, HMS
- Angela Shen, MD, Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
- Ralph Mazitschek, PhD, Principal Investigator, MGH Assistant Professor, HMS
- Shawn Demehri, MD, PhD, Director, High Risk Skin Cancer Clinic, MGH; MGH Research Scholar; Associate Professor, HMS
- Brian Wainger, MD, PhD, Trustees Endowed Scholar in Anesthesia and Alexander Healey Endowed Chair in ALS, Neurology & Anesthesia, Critical Care and Pain Medicine, MGH; Associate Professor, HMS
- Jordan Smoller, MD, ScD, Associate Chief for Research and Director, Center for Precision Psychiatry, Department of Psychiatry, MGH; Tepper Family MGH Research Scholar; Professor of Psychiatry, HMS
- Natalie Artzi, PhD, Associate Bioengineer, BWH; Associate Professor of Medicine, HMS
Biopharmaceuticals and The Inflation Reduction Act: A Status Report on IRA Implementation
- Moderator: Tom Hubbard, Senior Vice President, Network for Excellence in Health Innovation (NEHI)
Panelists - Peter Neumann, ScD, Director-CEVR, Tufts Medical Center
- Steven Pearson, MD, President, Institute for Clinical and Economic Review; Lecturer, Department of Population Medicine, HMS
The Inflation Reduction Act: The Emerging Implications for Biopharmaceutical Innovation
- Moderator: Tom Hubbard, Senior Vice President, Network for Excellence in Health Innovation (NEHI)
Panelists - Stephen Brady, CEO, Tempest Therapeutics
- Remy Brim, PhD, Principal, BGR Group
- Pat Fortune, PhD, Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
- John Lepore, MD, SVP, Head of Research, GSK
THE DR. IS IN | Mental Health Clinical Trials | Measurable vs. Hype
- Moderator: Kerry Ressler, MD, PhD, Chief Scientific Officer, McLean Hospital; Professor of Psychiatry, HMS
- Laura Germine, PhD, Co-Director of the Institute for Technology in Psychiatry, President of the Many Brains Project, McLean Hospital; Associate Professor of Psychiatry, HMS
- Philip Wang, MD, DrPH, Director of the Center for Learning Health Systems, BWH; Professor of the Practice of Psychiatry, HMS
- Moderator: Niyum Gandhi, Chief Financial Officer, Mass General Brigham
- Andrew Bressler, Managing Director, Global Research, BofA Securities
- Adam Harpool, Principal, Health & Digital, Oliver Wyman
- Cheryl Sadro, Chief Financial Officer, UC Davis Health
THE DR. IS IN | Academic Innovation’s Citadel | Wellman Center’s Unrivaled Translation
- Moderator: Rox Anderson, MD, Lancer Endowed Chair of Dermatology; Director, Wellman Center for Photomedicine, MGH; Professor of Dermatology, HMS
- Conor Evans, PhD, Principal Investigator, Wellman Center for Photomedicine, MGH; Associate Professor, HMS
- Lilit Garibyan, MD, PhD, Physician-Scientist, Wellman Center for Photomedicine, MGH; Associate Professor of Dermatology, HMS
THE DR. IS IN | Biotech Deal Making Draws Increasingly on Accelerators and Incubators Especially in America’s Innovation Hub
- Moderator: Roger Kitterman, Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
- Cait Brumme, CEO, MassChallenge Ann DeWitt, PhD, General Partner, The Engine
- Johannes Fruehauf, MD, PhD, Founder & General Partner, Mission BioCapital; Co-Founder & President, LabCentral; CEO, BioLabs
- Marc Succi, MD, Executive Director, Mass General Brigham MESH Incubator; Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; Strategic Innovation Leader, Mass General Brigham Innovation
- Moderator: Katherine Liao, MD, Associate Physician, Department of Rheumatology, Inflammation, and Immunity, BWH; Associate Professor of Medicine and Biomedical Informatics, HMS
- Moderator: Jeffrey Sparks, MD, Associate Physician, BWH; Associate Professor of Medicine, HMS
- Nicole LeBoeuf, MD, Chief of Oncodermatology, BHW; Vice Chair of Dermatology, Dana-Farber Brigham Cancer Center; Associate Professor of Dermatology, HMS
- Brittany Weber, MD, PhD, Director, Cardio-Rheumatology Clinic, Associate Physician, Prevention Cardiology and Cardiovascular Imaging, BWH; Instructor of Medicine, HMS
THE DR. IS IN | Generative AI, ChatGPT, and the Rapidly Changing Role of AI in Healthcare
- Moderator: Adam Landman, MD, Chief Information Officer and Senior Vice President, Digital, Mass General Brigham Associate Professor of Emergency Medicine, HMS
- Brian Anderson, MD, Chief Digital Health Physician, MITRE
- Ruth Carlos, MD, Professor of Radiology, University of Michigan
- Munjal Shah, Co-Founder & CEO, Hippocratic AI
- Varun Singh, PhD, President & Co-Founder, Moveworks
- Introducer: Scott Sperling, Co-CEO, Thomas H. Lee Partners; Chairman of the Board, Mass General Brigham
- Moderator: Jonathan Kraft, President, The Kraft Group; Chairman, Board of Trustees, MGH
- Anne Klibanski, MD, President & CEO, Mass General Brigham
- Brian Moynihan, Chair & CEO, Bank of America
- Maura Healey, Governor of the Commonwealth of Massachusetts
- Moderator: Meg Tirrell, Medical Correspondent, CNN
- Chris Viehbacher, President & CEO, Biogen
The Disruptors: The Next Wave of Promising Psychiatry and Neurology Drugs
- Moderator: Maurizio Fava, MD, Chair of Psychiatry, MGH; Slater Family Professor of Psychiatry, HMS
- Moderator: Greg Harrison, Vice President, Global Research, BofA Securities
- Joshua Cohen, Co-CEO, Amylyx Pharmaceuticals
- Steve Davis, CEO, Acadia Pharmaceuticals
- Justin Klee, Co-CEO, Amylyx Pharmaceuticals
- Ivana Magovcevic-Liebisch, PhD, President & CEO, Vigil Neuroscience
- Vimal Mehta, MD, CEO, BioXcel Therapeutics
- Moderator: Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, Co-Director, McCance Center for Brain Health, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
- Robert Waldinger, MD, Director, Harvard Study of Adult Development, MGH; Professor of Psychiatry, HMS
The Innovation Gap: Dissecting Emerging Modalities and Mechanisms for Treating CNS Diseases
- Moderator: Ole Isacson, MD, PhD, Director, Neuroregeneration Research Institute, McLean Hospital; Professor of Neurology and Neuroscience, HMS
- Moderator: Charlie Yang, PhD, Vice President, US Biopharmaceutical Equity Research Analyst, BofA Securities
- Lisa Ricciardi, President & CEO, Cognition Therapeutics
- Kasper Roet, PhD, CEO & Co-Founder, QurAlis
- Robert Scannevin, PhD, Chief Scientific Officer, Verge Genomics
- Moderator: Merit Cudkowicz, MD, Chair, Department of Neurology, MGH; Julieanne Dorn Professor of Neurology, HMS
- Moderator: Aamir Mecklai, Managing Director, Healthcare Investment Banking, BofA Securities
- Janice Chen, PhD, Co-Founder & CTO, Mammoth Biosciences
- Olivier Danos, EVP and Chief Scientific Officer, REGENXBIO
- Zhen Li, PhD, President & CEO, ADARx Pharmaceuticals
- Catherine Stehman-Breen, MD, CEO, Chroma Medicine
- R. Nolan Townsend, CEO, LEXEO Therapeutics
- Moderator: David Brown, MD, President, Mass General Hospital; MGH Trustees Professor of Emergency Medicine, HMS
- Kate Walsh, Secretary of Health and Human Services, State of Massachusetts
- Moderator: Michael Cherny, Managing Director, Senior Equity Research Analyst, BofA Securities
- Moderator: Niyum Gandhi, Chief Financial Officer, Mass General Brigham
- Sree Chaguturu, MD, Senior Vice President and Chief Medical Officer CVS Health
Tuesday, June 13, 2023
- Moderator: Geoff Meacham, PhD, Managing Director, Global Research, BofA Securities
- Paula Ness, Speers Co-Founder & Senior Advisor, Health Advances
- Arpa Garay, Chief Commercial Officer, Moderna
The Disruptors: The Biologic Revolution in Cancer Continues
- Moderator: Daniel Haber, MD, PhD, Director, Mass General Cancer Center; Kurt J. Isselbacher Professor of Oncology, HMS
Panelists - Bill Lundberg, MD, CEO, Merus
- Thomas Schuetz, MD, PhD, CEO & Co-Founder, Compass Therapeutics
- Fred Schwarzer, CEO, IGM Biosciences
The Innovation Gap: Crumblin’ Down – Driving Cell Therapy into Solid Tumors
- Moderator: Tazeen Ahmad, Managing Director, Global Research, BofA Securities
- Moderator: Angela Shen, MD, Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
- Corinne Le Goff, PharmD, President & CEO, Imunon
- Ryan Richardson, Chief Strategy Officer, BioNTech
- Lynn Seely, MD, President & CEO, Lyell
A Deep Dive on Targeted Oncology: Small Molecule Discovery and Development Remains Robust
- Moderator: Keith Flaherty, MD, Director of Clinical Research, Mass General Cancer Center; Professor of Medicine, HMS
- Moderator: Jason Gerberry, Biopharma Equity Research Analyst, Bank of America
- Stephen Brady, CEO, Tempest Therapeutics
- Zachary Hornby, CEO, Boundless Bio
- James Porter, PhD, CEO, Nuvalent
Capital Formation: Putting Money to Work – State of Affairs in Capital Markets
- Moderator: Greg Butz, Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities
- Moderator: Yvonne Hao, Secretary of Economic Development, Commonwealth of Massachusetts
- Moderator: Sumit Mukherjee, Managing Director, Co-Head of Origination, Americas Equity Capital Markets, BofA Securities
- Jean-François Formela, MD, Partner, Atlas Venture
- Craig Gordon, MD, Founder, CEO & CIO, GordonMD Global Investments
- Roger Kitterman, Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
- Nimish Shah, Partner, Venrock
Lunch & The Bigger Economic Picture
- Moderator: Miceal Chamberlain, President, Massachusetts, Bank of America
- Michael Gapen, PhD, Head of US Economics Research, Bank of America
- Moderator: Geoff Meacham, PhD, Managing Director, Global Research, BofA Securities
- David Ricks, Chair & CEO, Eli Lilly and Company
The Disruptors: What’s Next for Cell Therapy in Liquid Tumors?
- Moderator: Noopur Raje, MD, Director, Center for Multiple Myeloma, Mass General Cancer Center; Professor of Medicine, HMS
- Moderator: Alec Stranahan, PhD, Vice President, Global Research, BofA Securities
- Chip Baird, CFO, 2seventy bio
- Steve Harr, MD, President & CEO, Sana Biotechnology
- Laura Sepp-Lorenzino, PhD, Executive Vice President, Chief Scientific Officer, Intellia Therapeutics
Fireside Chat
- Introducer: Yvonne Hao, Secretary of Economic Development, Commonwealth of Massachusetts
- Moderator: Andrew Bressler, Managing Director, Global Research, BofA Securities
- Moderator: Adam Koppel, MD, PhD, Partner, Bain Capital Life Sciences
- Renee Wegrzyn, PhD, Director, Advanced Research Projects Agency for Health
The Innovation Gap: The Promise of Precision Oncology for Liquid Tumors
- Moderator: Elisabeth Battinelli, MD, PhD, Physician, BWH; Associate Professor, HMS
- Moderator: John Bishai, PhD, Managing Director, Healthcare Investment Banking, BofA Securities
- Adi Hoess, MD, PhD, CEO, Affimed
- Barry Kappel, PhD, Founder, President & CEO, Sapience Therapeutics
- Troy Wilson, PhD, President & CEO, Kura Oncology
A Deep Dive on Cell Therapy: Applying Lessons Learned from First-Generation Cell Therapies
- Moderator: David Ting, MD, Associate Clinical Director for Innovation, Mass General Cancer Center; Associate Professor of Medicine, HMS
- Moderator: Jason Zemansky, PhD, Vice President, Global Research, BofA Securities
- Tom Barnes, PhD, CEO, Orna Therapeutics
- David Main, CEO, Notch Therapeutics
- Andrew Schiermeier, PhD, President & CEO, AvenCell Therapeutics
- Moderator: Tazeen, Ahmad, Managing Director, Global Research, BofA Securities
- Moderator: Lindsey Baden, MD, Vice President Clinical Research, BWH; Professor, HMS
- Robert Califf, MD, Commissioner, US Food and Drug Administration
M&A and Business Development Roundtable: Who Wants to Make a Deal – Biopharma M&A/BD Perspectives
- Moderator: Greg Butz, Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities
- Moderator: Adrian Mee, Managing Director, Head of Global Healthcare Investment Banking, BofA Securities
- Said Francis, SVP, Business Development and Corporate Strategy, Moderna
- Rachna Khosla, Senior Vice President, Business Development, Amgen
Evan Lippman, Chief Corporate Development & Strategy Officer, Alnylam
Wednesday, June 14, 2023
Fireside Chat
- Moderator: Keith Kerman, MD, Operating Partner & Senior Advisor, The Riverside Company
- Moderator: Geoff Meacham, PhD, Managing Director, Global Research, BofA Securities
- Scott Gottlieb, MD, Former Commissioner, Food and Drug Administration (2017-2019)
The Disruptors: Driving I&I Therapy Adoption with Oral Formulations
- Moderator: Steven Greenberg, MD, Neurologist, BWH; Professor of Neurology, HMS
- Natalie Holles, CEO, Third Harmonic Bio
- Kevin Judice, PhD, CEO & Founder, DICE Therapeutics
- Rosana Kapeller, MD, PhD, CEO, ROME Therapeutics
- Andre Turenne, CEO, Matchpoint Therapeutics
The Innovation Gap: Old Dog, New Tricks – Reprogramming the Immune System
- Moderator: Ellen Gravallese, MD, Chief of Rheumatology, Inflammation, and Immunity, BWH; Theodore Bevier Bayles Professor of Medicine, HMS
- Moderator: Alexandria Hammond, PhD, Vice President, Global Research, BofA Securities
- Diana Brainard, MD, CEO, AlloVir
- Deborah Geraghty, PhD, President & CEO, Anokion
- Samantha Singer, President & CEO, Abata Therapeutics
A Deep Dive on Newly Validated Modalities: The Pathway Less Traveled – Emerging Targets in I&I
- Moderator: Susan Chor, Equity Research Associate, BofA Securities
- Moderator: Karen Costenbader, MD, Director, Lupus Program, BWH; Professor of Medicine, HMS
- Tariq Kassum, MD, CEO, Celsius Therapeutics
- Jodie Morrison, CEO, Q32 Bio
- Jason Springs, Co-Founder & CEO, Endpoint Health
- Moderator: Vijay Kuchroo, DMV, PhD, Director, Evergrande Center for Immunologic Diseases, BWH; Samuel L. Wasserstrom Professor of Neurology, HMS
- Moderator: Geoff Meacham, PhD, Managing Director, Global Research, BofA Securities
- Mikael Dolsten, MD, PhD, Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer
- Moderator: Paul Anderson, MD, PhD, Acting Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
- Moderator: Lilit Garibyan, MD, PhD, Physician-Scientist, Wellman Center for Photomedicine, MGH; Associate Professor of Dermatology, HMS
- Moderator: Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, Co-Director, McCance Center for Brain Health, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
- Rachel Whooten, MD, Pediatric Endocrinologist, MGH; Assistant Professor, HMS
- Steven Arnold, MD, Director, Alzheimer’s Clinical & Translational Research Unit, Translational Neurology Head & Managing Director, Interdisciplinary Brain Center, MGH; Professor of Neurology, HMS
- Joan Miller, MD, Chief of Ophthalmology, Mass Eye and Ear and MGH; Ophthalmologist-in-Chief, BWH; David Glendenning Cogan Professor of Ophthalmology, HMS
- Florian Fintelmann, MD, Radiologist, Physician-Scientist, MGH; Associate Professor of Radiology, HMS
- David Ting, MD, Associate Clinical Director for Innovation, Mass General Cancer Center; Associate Professor of Medicine, HMS
- Stephanie Seminara, MD, Chief, Reproductive Endocrine Unit, MGH; Professor of Medicine, HMS
- Roger Hajjar, MD, Director, Gene & Cell Therapy Institute Mass General Brigham
- Vesela Kovacheva, MD, PhD, Director of Translational and Clinical Research, BWH; Assistant Professor of Anesthesia, HMS
- James Berry, MD, Neurologist/ALS Clinical Researcher, MGH; Associate Professor, HMS
- Lindsey Baden, MD, Vice President Clinical Research, BWH; Professor, HMS
- Chadi El Saleeby, MD, Associate Pediatrician, Mass General for Children; Assistant Professor of Pediatrics, HMS
- Gerard Doherty, MD, Surgeon-in-Chief, BWH; Moseley Professor of Surgery, HMS
Sponsors
